Teladoc and Livongo Health shareholders approve the companies' merger

Teladoc Health and Livongo Health investors, in separate special shareholder meetings, overwhelmingly voted in favor of the merger of the two companies. Teladoc revealed this in a press release issued on Thursday, adding that in both cases, more than 99% of voters approved the deal. The merger was announced in August. It will take the form of a share exchange, in which one share of Livongo will be swapped for 0.592 shares of Teladoc and $11.33 in cash; all told, the deal was valued at $18.5 billion.